Treatment with somatostatin analogs induces differentially expressed let-7c-5p and mir-3137 in small intestine neuroendocrine tumors

• Published in: BMC cancer 2019-06, Vol.19 (1), p.575-575, Article 575
• Main Authors: Bösch, Florian, Bazhin, Alexandr V, Heublein, Sabine, Brüwer, Katharina, Knösel, Thomas, Reiter, Florian P, Auernhammer, Christoph J, Guba, Markus O, Spitzweg, Christine, Werner, Jens, Angele, Martin K
• Format: Article
• Language: English
• Subjects: Aged; Antineoplastic Agents - therapeutic use; Apoptosis; Biological Variation, Population; Biomarkers; Breast cancer; Cancer metastasis; Care and treatment; Cell growth; Colorectal cancer; Female; Gene expression; Gene Expression Profiling; Humans; Intestinal Neoplasms - drug therapy; Intestine, Small - pathology; Intra-individual; Kinases; Liver; Lung cancer; Lymphatic system; Male; Medical research; Metastases; Metastasis; MicroRNA; MicroRNAs; MicroRNAs - genetics; Middle Aged; Neuroendocrine tumor; Neuroendocrine tumors; Neuroendocrine Tumors - drug therapy; Patients; Prospective Studies; Ribonucleic acid; RNA; Small intestine; Somatostatin; Somatostatin - analogs & derivatives; Somatostatin - therapeutic use; Surgery; Tumors
• ISSN: 1471-2407; 1471-2407
• DOI: 10.1186/s12885-019-5794-y

Distant metastases frequently occur in gastroenteropancreatic neuroendocrine tumors. If hepatic surgery is not feasible, patients are treated with somatostatin analogs. However, the underlying mechanisms of action of this treatment remain to be defined. The aim of the present study was to analyze the micro-RNA expression profile inter-individually before and after the treatment with somatostatin analogs. Tumor specimens of all included patients (n = 8) before and after the onset of a therapy with somatostatin analogs were analyzed and a micro-RNA expression profile (754 micro-RNAs) of each probe was generated. This analysis in an intra-individual setting was selected to avoid bias from inter-individual differences. The micro-RNA expression profiles were validated by qPCR. Patients with any other systemic treatment were excluded from the present study. Eight patients were included in the present study of which all had neuroendocrine tumors of the small intestine with diffuse hepatic metastases. Grouped analyses revealed that 15 micro-RNAs were differentially expressed (3 up- and 12 downregulated) after the exposure to somatostatin analogs. Additionally, let-7c-5p and mir-3137 are concordantly regulated in the inter-individually analysis. This is the first study analyzing the individual micro-RNA expression profile before and after a therapy with somatostatin analogs. Data from this study reveal that somatostatin analogs may in part exert their beneficial effects through an alteration in the micro-RNA expression profile.